Mendelian randomization (MR) analysis showed that, in female APOE-ε4 carriers, decreased sST2 level results in reduced AD risk and less-severe AD-associated endophenotypes, suggesting a causal effect of sST2 in AD. This evidence concerns the gene APOE and Alzheimer disease.